Autoimmune Diseases  >>  inactivated VZV vaccine (V212)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
inactivated VZV vaccine (V212) / Merck (MSD)
NCT01527383 / 2011-002313-11: A Study to Evaluate the Safety and Immunogenicity of Inactivated Varicella Zoster Virus (VZV) Vaccine in Adults With Autoimmune Disease (V212-009)

Completed
2
354
NA
V212, Inactivated Varicella-Zoster (VZV) vaccine, Placebo
Merck Sharp & Dohme LLC
Herpes Zoster
02/13
02/13

Download Options